Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lukas, Aspacher"'
Autor:
Jan A. Stratmann, Radha Timalsina, Akin Atmaca, Vivian Rosery, Nikolaj Frost, Jürgen Alt, Cornelius F. Waller, Niels Reinmuth, Gernot Rohde, Felix C. Saalfeld, Aaron Becker von Rose, Fabian Acker, Lukas Aspacher, Miriam Möller, Martin Sebastian
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Objectives: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective salvage therapies are urgently needed. Materials and Methods: We ai
Externí odkaz:
https://doaj.org/article/3241382465814be1b90a998fcc16090e
Autor:
Fabian Acker, Jan Stratmann, Lukas Aspacher, Ngoc Thien Thu Nguyen, Sebastian Wagner, Hubert Serve, Peter J. Wild, Martin Sebastian
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
KRAS is one of the most commonly mutated oncogenes in cancer, enabling tumor proliferation and maintenance. After various approaches to target KRAS have failed over the past decades, the first specific inhibitor of the p.G12C mutation of KRAS was rec
Externí odkaz:
https://doaj.org/article/302cff3e58874357be4314cba00d3fc1
Autor:
Johanna Kessel, Michael Hogardt, Lukas Aspacher, Thomas A. Wichelhaus, Jasmin Gerkrath, Emely Rosenow, Jan Springer, Volker Rickerts
Publikováno v:
Journal of Fungi, Vol 8, Iss 3, p 306 (2022)
Invasive fungal infections are associated with increased mortality in hematological patients. Despite considerable advances in antifungal therapy, the evaluation of suspected treatment failure is a common clinical challenge requiring extensive diagno
Externí odkaz:
https://doaj.org/article/e7cc01b82e0f429fbba4a0e445c6954a
Autor:
Sebastian Scheich, Julius C Enßle, Victoria T Mücke, Fabian Acker, Lukas Aspacher, Sebastian Wolf, Anne C Wilke, Sarah Weber, Uta Brunnberg, Hubert Serve, Björn Steffen
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225035 (2019)
Autologous hematopoietic stem cell transplantation (auto-HSCT) provides a potentially curative treatment option for relapsed and refractory lymphomas. Obesity displays an emerging epidemic risk factor for global mortality and is associated with an in
Externí odkaz:
https://doaj.org/article/96bbd8b99650499b9eb131015f2b0a66
Autor:
Jan A, Stratmann, Radha, Timalsina, Akin, Atmaca, Vivian, Rosery, Nikolaj, Frost, Jürgen, Alt, Cornelius F, Waller, Niels, Reinmuth, Gernot, Rohde, Felix C, Saalfeld, Aaron Becker, von Rose, Fabian, Acker, Lukas, Aspacher, Miriam, Möller, Martin, Sebastian
Publikováno v:
Therapeutic advances in medical oncology. 14
Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective salvage therapies are urgently needed.We aimed to define efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efc7fab4939945247a3269209fed62fd
https://pubmed.ncbi.nlm.nih.gov/35677321
https://pubmed.ncbi.nlm.nih.gov/35677321
Autor:
Jan Alexander Stratmann, Fabian Acker, Lukas Aspacher, Juergen Alt, Friederike C Althoff, Sophie Heinzen, Nicola Gökbuget, Ina Müller, Lena Reiser, Sina Hehn, Hubert Serve, Martin Mänz, Frauke Meyer, Martin Sebastian
Publikováno v:
Journal of Clinical Oncology. 40:TPS9157-TPS9157
TPS9157 Background: Epidermal growth factor receptor (EGFR) – mutated non-small cell lung cancer (NSCLC) is susceptible to EGFR targeting tyrosine kinase inhibitors (TKI), such as the third generation TKI osimertinib. However, response rate and dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::097c9a070af0d2caaad860246763339a
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9157
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9157
Autor:
Anne C. Wilke, Hubert Serve, Uta Brunnberg, Julius C. Enßle, Fabian Acker, Sebastian Wolf, Sebastian Scheich, Sarah Weber, Björn Steffen, Lukas Aspacher, Victoria T. Mücke
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 11, p e0225035 (2019)
PLoS ONE, Vol 14, Iss 11, p e0225035 (2019)
Autologous hematopoietic stem cell transplantation (auto-HSCT) provides a potentially curative treatment option for relapsed and refractory lymphomas. Obesity displays an emerging epidemic risk factor for global mortality and is associated with an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a23761650e153d2a4b1598b41cd57f
https://doi.org/10.1371/journal.pone.0225035
https://doi.org/10.1371/journal.pone.0225035